Onkos Molecular Diagnostics

*Problem:* Around 80% of thyroid diagnostic surgeries are unnecessary. A patient without the thyroid is a new chronic and expensive patient for the healthcare system. *Solution:* A proprietary molecular diagnostic test, merging Genomics + predictive AI, with strong scientific evidence from clinical validation studies published in high impact journals, IP protected, that reduces up to 75% of thyroid unnecessary surgeries with 96% confidence. More than 7.000 patients tested from all continents since 2018. *Looking for:* - Investors to join us in the international expansion, due to active claim from guidelines. - Hospitals and Clinics that want to offer the cutting edge, guideline aligned, patient journey care. - Qualified networking - R&D opportunities for colaborations *Technology Readiness Level:* TRL 9 Contact info: Marcos Santos, PhD - Founder & CEO marcos@onkos.com.br https://www.linkedin.com/in/marcostadeudossantos/ +55 (16) 9.9741-9547 #deeptech #healthtech #medtech #biotech #thyroid #cancer #diagnostics #molecular #genetic #molecular #microRNA #RNA #oncology #surgery #saving #genomics #expression #mir-thype #patent #evidence #PhD #science #scientific #founder #CEO #laboratory